APA (7th ed.) Citation

Yuan, R., Xin, Q., Shi, W., Miao, Y., Zhu, Z., Yuan, Y., . . . Cong, W. Tetramethylpyrazine and paeoniflorin combination (TMP-PF) alleviates atherosclerosis progress by reducing hyperlipemia and inhibiting plaque angiogenesis via the NR4A1/VEGFR2 pathway. Tsinghua University Press.

Chicago Style (17th ed.) Citation

Yuan, Rong, et al. Tetramethylpyrazine and Paeoniflorin Combination (TMP-PF) Alleviates Atherosclerosis Progress by Reducing Hyperlipemia and Inhibiting Plaque Angiogenesis via the NR4A1/VEGFR2 Pathway. Tsinghua University Press.

MLA (9th ed.) Citation

Yuan, Rong, et al. Tetramethylpyrazine and Paeoniflorin Combination (TMP-PF) Alleviates Atherosclerosis Progress by Reducing Hyperlipemia and Inhibiting Plaque Angiogenesis via the NR4A1/VEGFR2 Pathway. Tsinghua University Press.